Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit ...

What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 7.5% in the morning session after ...

Shares of Charles River Laboratories International Inc. advanced 9.06% to $163.36 Tuesday, on what proved to be an all-around ...

Business: Charles River Laboratories is an early-stage contract research company. The company engages in laboratory animal medicine and science (research model technologies), and it has developed ...

Charles River Laboratories International had a return on equity of 14.69% and a net margin of 0.52%. The company’s quarterly revenue was down 2.7% compared to the same quarter last year.

Charles River Laboratories International, Inc. today reported its results for the third quarter of 2023. For the quarter, revenue was $1.03 billion, an increase of 3.8% from $989.2 million in the ...

Charles River Laboratories International, Inc. (NYSE:CRL) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. As a large-cap stock with high coverage by ...

Charles River isn’t the only CRO to have struggled in the third quarter. Irish firm Icon reported third-quarter revenue of $2.03 billion, underperforming analyst expectations of $2.14 billion ...

Charles River Laboratories International Inc. (NYSE: CRL), fresh from the collapse of a proposed, $1.6 billion merger with WuXi PharmaTech (Cayman) Inc. (NYSE: WX), plans to accelerate a $300 ...

Charles River Laboratories' share price has declined over 50% from its 2021 peak, presenting a potential buying opportunity for investors. The CRO company is facing headwinds from COVID's overhang ...

Charles River Laboratories Stock Return (Recent) Comparison With Peers And S&P500 Five-Day Return: CRL highest at 1.7%; KW lowest at -2.6% Ten-Day Return: CRL highest at 5.8%; CBZ lowest at 0.3% ...